Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : NetCurrents NTCS -- Ignore unavailable to you. Want to Upgrade?

To: bobby is sleepless in seattle who wrote (4332)	11/10/2000 11:22:32 PM
From: bobby is sleepless in seattle	Read Replies (1) \| Respond to of 8925

and where's the beef?...I would expect to see greater volume levels to give meaning to this selloff. Also, Message 14690710 WHAT TO EXPECT NOW. October 30, 2000. Ord Oracle. On today's rally on the SPX a 767 uptick readings was recorded. Uptick readings exceeding 600 appear near short-term highs. The "5 day ARMS" came in today at 4.76, which is on the bearish side of neutral. The market is giving signs that it is running into resistance. The previous high on the December S&P's came on October 24 at the 1428.50 level on volume of 1.153 billion shares. If the market tests that area on lighter volume than 1.153 billions shares and a bearish candlestick pattern shows up on that test and a high uptick reading coincides, a potential sell signal could get triggered. That is a lot to ask for, but if these conditions materialize, it should not be ignored. The Nasdaq Composite is giving more bullish signs than the S&P's. For starters the "5 day ARMS" on the Nasdaq has stayed at a higher level in the bullish camp. The "5 day ARMS" on the Nasdaq closed at a new short term high of 7.68 today. Readings above 5.25 are bullish on the Nasdaq. On today's decline the volume shrank to 1.74 billions shares, one of the lightest volume days for a while. When a market pulls back on light volume a bullish occurrence has developed. There may be one more pull back to test the October 18 low near the 3030 area. If that is test is on lighter volume than the October 18 volume (2.50 billions shares), a buy signal could develop that could take the Nasdaq composite to 4300 area. We are bullish on the Nasdaq, but no buy signal yet. We are bullish on gold. We are holding our long position in the XAU. marketweb.com

To: bobby is sleepless in seattle who wrote (4332)	11/11/2000 9:03:26 AM
From: kha vu	Respond to of 8925

AFFX: another big mess here in the web of legal process. Full article in Sat NY times: nytimes.com <<<Susan E. Siegel, president of Affymetrix, said the jury did not find the infringement willful, meaning that damages awarded to Oxford could not be tripled. She also said that Judge Joseph J. Farnan Jr. had confirmed the British decision that Affymetrix had a license. "We're pretty pleased with the ruling over all," she said. Oxford does not acknowledge that Affymetrix has a license and has said it will appeal the British court decision. Oxford has refused to cash the royalty checks being sent by Affymetrix under the Beckman-Coulter license. ... Oxford has already licensed its gene chip patent to Incyte Genomics, which has been sued by Affymetrix for patent infringement, and to Agilent. Dr. Millar said that Oxford would grant a license to Affymetrix but would insist in return that Affymetrix grant licenses for its patents to Agilent, Incyte and other companies. Gene chips are pieces of glass or plastic about the size of a microscope slide on which thousands of genes or gene fragments can be placed. The chips can be used to find which of thousands of genes are active in a given cell. They can also be used to test which variations of particular genes a person has. >>>>>>>>>